Nicolino Ruperto

63PUBLICATIONS
166CO-AUTHORS
Toxicology (incl. clinical toxicology)Diagnostic radiographyAdolescent healthPredictive and prognostic markersInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (63)

|Oct 08, 2025
Impact of Concomitant Methotrexate Use and Prior Biologic Disease-Modifying Antirheumatic Drug Exposure on Tofacitinib Efficacy and Safety in Patients with Polyarticular Course Juvenile Idiopathic Arthritis: Post Hoc Analysis of a Phase 3 Randomized Withdrawal Trial.

Nicolino Ruperto, Daniel J Lovell, Olga Synoverska

|Jan 15, 2025
Effect of Characteristic Inflammatory and Structural Pelvic Magnetic Resonance Imaging Lesions on Expert Assessment of Axial Juvenile Spondyloarthritis.

Adam Mayer, Timothy G Brandon, Amita Aggarwal

|Dec 25, 2024
Do the Provisional Paediatric Rheumatology International Trials Organisation Enthesitis/Spondylitis-Related Juvenile Idiopathic Arthritis Criteria Capture Youth With Axial Spondyloarthritis?

Pamela F Weiss, Timothy G Brandon, Amita Aggarwal

|Nov 03, 2024
Transcriptional Profiling of Tofacitinib Treatment in Juvenile Idiopathic Arthritis: Implications for Treatment Response Prediction.

Esraa Eloseily, Alex Pickering, Sanjeev Dhakal

|Oct 10, 2024
Factors for Consideration by Pediatric Rheumatologists When Scoring the Physician Global Assessment of Disease Activity in Juvenile Idiopathic Arthritis: First Step Toward an Internal Consensus.

Maarit Tarkiainen, Erin Balay-Dustrude, Alessandro Consolaro

|Sep 12, 2024
Summary of Research: Ten-Year Safety and Clinical Benefit from Open-Label Etanercept Treatment in Children and Young Adults with Juvenile Idiopathic Arthritis.

Jelena Vojinović, Ivan Foeldvari, Joke Dehoorne

Pageof 11

Frequent Collaborators

22 joint publications

Hermine I Brunner

15 joint publications

Daniel Lovell

10 joint publications

Angelo Ravelli

6 joint publications

Ozgur Kasapcopur